Skip to content

Effect of electrical stimulation therapy for peroneus longus muscle in patients with hallux valgus

Open-label, exploratory clinical trial of electrical stimulation therapy for peroneus longus muscle in patients with hallux valgus - Electrical stimulation therapy of peroneus longus muscle for hallux valgus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053301
Enrollment
20
Registered
2024-01-09
Start date
2024-01-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hallux Valgus

Interventions

Electrical muscle stimulation of the peroneus longus muscle using low frequency treatment device

Sponsors

Hiroshima University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are at least 18 years of age and under 70 years of age at the time consent is obtained. (Male and female) 2. Patients who meet the diagnostic criteria of hallux valgus within one month before registration. (Hallux valgus angle less than 50 degrees) 3. Patients who can visit outpatient clinic for 28 weeks. 4. Patients who can provide written consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients who already performed physical therapy (strength training of the abductor hallucis muscle) within one month before registration. 2. Patients who have subluxation of the first metatarsophalangeal joint. (Hallux valgus angle over 50 degrees) 3. Patients who have dislocation of the lesser metatarsophalangeal joint. 4. Patients who have moderate flatfoot deformity. (Lateral talo-first metatarsal angle over 15 degrees) 5. Patients who take nonsteroidal anti-inflammatory drugs regularly within 4 weeks before registration. 6. History of cerebral vascular disease, neuromuscular disease, or hemiplegia. 7. History of serious side effects by low frequency treatment device. 8. Patients who meet the contraindication of the low frequency treatment device. 9. Women who are pregnant or may become pregnant, who are breastfeeding or who wish to become pregnant. 10. Patients who have participated or are willing to participate in other clinical trials during participation in the current study. 11. Patient who may suffer an unjust disadvantage by participating in this study, or disturbing the specific assessment in the current study. 12. Individuals who are investigator of the current study or employee of this hospital, or whose family.

Design outcomes

Primary

MeasureTime frame
Hallux valgus angle on standing plain radiograph

Countries

Japan

Contacts

Public ContactYasunari Ikuta

Hiroshima University Hospital Department of Orthopaedic Surgery

yikuta@hiroshima-u.ac.jp082-257-5470

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026